Vol. 12. Núm. S2.
Páginas 11-13 (Junio 2005)

Tratamiento de la enfermedad cerebrovascular aguda

Opciones

Identifíquese

¿Aún no es suscriptor de la revista?

Comprar el acceso al artículo

Comprando el artículo el pdf del mismo podrá ser descargado

Teléfono para incidencias

De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h

Llamadas desde España 932 415 960
Llamadas desde fuera de España +34 932 415 960
Bibliograf¿a
[1]
Atención hospitalaria organizada (unidad de accidentes cerebrovasculares) para el accidente cerebrovascular. En: Cochrane Library plus en español. Oxford: Update Software; 2001.
[2]
Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003;34:1056-83.
[3]
European Stroke Initiative Recommendations for Stroke Management. Update 2003. Cerebrovasc Dis. 2003;16:311-37.
[4]
Surgery for primary intracerebral hemorrhage: is it safe and effective? A systematic review of case series and randomized trials. Stroke. 1997;28:2126-32.
[5]
Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology. 1998; 50:876-83.
[6]
Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2:81-4.
[7]
Stroke. 1999;30:2033-7.
[8]
Blood pressure and clinical outcomes in the International Stroke Trial. Stroke. 2002; 33:1315-20.
[9]
Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997;314:1303-6.
[10]
Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke. 1999;30:793-9.
[11]
Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke. 2000;31:410-4.
[12]
Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333:1581-7.
[13]
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet. 1997;349:1569-81.
[14]
Anticoagulants and antiplatelet agents in acute ischemic stroke. Stroke. 2002;33:1934-42.
[15]
Popularion based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ. 2004;328:326-8.
[16]
Very early risk of stroke after a first transient ischemic attack. Stroke. 2003;34:138-40.
[17]
Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284:2901-6.
[18]
Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ. 2004;170:1105-9.
[19]
Life alter stroke. New Zealand guidline for management of stroke. Best practice evidente guideline. November 2003 [citado 10 Jul 2004]. Disponible en: http://www.nzgg.org.nz
[20]
Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 1999;30:1991-4.
[21]
Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 1993; 342:1255-62.
[22]
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a metaanalysis. Ann Intern Med. 1999;131:492-501.
[23]
Effect of endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and to the timing of surgery. Lancet. 2004;363:915-24.
[24]
Guía de actuación clínica en el ataque isquémico transitorio [citado el 10 de agosto 2004]. Disponible en: http://www.sen.es/formacion/ictus/AITGuiadoc.htm
[25]
The Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for the prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.